Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Sintilimab

    DEVELOPMENTS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hutchmed Expands Its NRDL Coverage, Joins First Commercial List
    Hutchmed Expands Its NRDL Coverage, Joins First Commercial List

    07 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201158/0/en/HUTCHMED-Announces-Expanded-Coverage-on-National-Reimbursement-Drug-List-and-Inclusion-in-the-First-Commercial-Insurance-Drug-List-in-China.html

    GLOBENEWSWIRE
    07 Dec 2025
    Share Share
    Hutchison China Meditech Showcases Clinical Data At 2025 ESMO
    Hutchison China Meditech Showcases Clinical Data At 2025 ESMO

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/27/3195434/0/en/HUTCHMED-Highlights-Clinical-Data-to-be-Presented-at-the-2025-ESMO-Asia-Congress-and-the-2025-ASH-Annual-Meeting.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    HUTCHMED to Present FRUSICA-2 Trial Data at ESMO 2025
    HUTCHMED to Present FRUSICA-2 Trial Data at ESMO 2025

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165267/0/en/HUTCHMED-Highlights-FRUSICA-2-Registration-Trial-Data-to-be-Presented-at-the-2025-ESMO-Congress.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share
    Hutchmed Showcases Clinical Data At Esmo Congress 2025
    Hutchmed Showcases Clinical Data At Esmo Congress 2025

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/02/3160056/0/en/HUTCHMED-Highlights-Clinical-Data-to-be-Presented-at-the-ESMO-Congress-2025.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    Hutchmed, Innovent File NDA in China for Renal Cell Carcinoma
    Hutchmed, Innovent File NDA in China for Renal Cell Carcinoma

    06 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/04/3094067/0/en/HUTCHMED-and-Innovent-Jointly-Announce-NDA-Acceptance-in-China-for-Fruquintinib-Combination-with-Sintilimab-for-the-Treatment-of-Advanced-Renal-Cell-Carcinoma.html

    GLOBENEWSWIRE
    06 Jun 2025
    Share Share
    HUTCHMED and Innovent announce FRUSICA-2 study success in China
    HUTCHMED and Innovent announce FRUSICA-2 study success in China

    18 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/19/3045072/0/en/HUTCHMED-and-Innovent-Jointly-Announce-that-the-FRUSICA-2-Phase-II-III-Study-of-Fruquintinib-and-Sintilimab-Combination-Has-Met-its-Primary-Endpoint-in-Advanced-Renal-Cell-Carcinom.html

    GLOBENEWSWIRE
    18 Mar 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.